[Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents]

Nihon Naika Gakkai Zasshi. 2009 Apr 10;98(4):737-41. doi: 10.2169/naika.98.737.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Cyclohexanes / administration & dosage*
  • Cyclohexanes / pharmacology
  • Diabetes Mellitus / drug therapy*
  • Glyburide / administration & dosage*
  • Glyburide / pharmacology
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / pharmacology
  • Infant, Newborn
  • Insulin / metabolism*
  • Insulin Secretion
  • KATP Channels / chemistry
  • KATP Channels / genetics
  • KATP Channels / physiology
  • Mutation
  • Nateglinide
  • Phenylalanine / administration & dosage
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / pharmacology
  • Stimulation, Chemical
  • Sulfonylurea Compounds / administration & dosage*
  • Sulfonylurea Compounds / pharmacology

Substances

  • Cyclohexanes
  • Hypoglycemic Agents
  • Insulin
  • KATP Channels
  • Sulfonylurea Compounds
  • Nateglinide
  • Phenylalanine
  • Glyburide